Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus

Yen, FS; Wang, HC; Pan, CW; Wei, JCC; Hsu, CC; Hwu, CM

Hwu, CM (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, 155,Sec 2,Linong St, Taipei 11221, Taiwan.; Hwu, CM (corresponding author), Taipei Vet Gen Hosp, Dept Med, Sect Endocrinol & Metab, 201,Sect 2 Shi Pai Rd,Chung Cheng Bldg, Taipei 11217, Taiwan.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020; 105 (3): E401

Abstract

Context: The long-term safety and benefit of pioglitazone use in combination with insulin are still uncertain. Objective: This study compared the risk......

Full Text Link